Influcid

Medicinal product

(Invented) name

Influcid

Active substance (s)

Aconitum trit. D3/Gelsemium trit. D3/Ipecacuanha trit. D3/Phosphorus trit. D5/Bryonia D2/Eupatorium perfoliatum trit. D1

Strength

25 mg/25 mg/25 mg/25 mg/25 mg/25 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2019-11-19

Date of renewal

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Aconitum trit. D3	25 mg
Gelsemium trit. D3	25 mg
Ipecacuanha trit. D3	25 mg
Phosphorus trit. D5	25 mg
Bryonia D2	25 mg
Eupatorium perfoliatum trit. D1	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102847	88948	1088948	lizdinė plokštelė	N40		Nereceptinis	LT/L/19/1110/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2024-02-21	Išregistruotas
2019-11-19	Registruotas